Abbott Laboratories (ABT) operating KPIs
Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%
Abbott Laboratories vascular Division (XIENCE DES, Esprit BTK Dissolving Stent, Diamondback 360 Atherectomy) — U.S. Revenue ($M) ($M)
Form 8-K Quarterly Earnings Releases (Item 2.02 Revenue Tables) & Form 10-K/10-Q MD&A
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up vascular division (xience des, esprit btk dissolving stent, diamondback 360 atherectomy) — u.s. revenue ($m)
Cite this data
StockData. (2026). Abbott Laboratories Vascular Division (XIENCE DES, Esprit BTK Dissolving Stent, Diamondback 360 Atherectomy) — U.S. Revenue ($M) ($M), quarterly Q4 2015–Q3 2026 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/md-vasc-rev-us
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.